Clinical Trial

Cell-Free DNA Chromatin Immunoprecipitation (ChIP) for Diagnosing Cancer

Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated December 6, 2024 (before its estimated May 2025 completion). Its status may not reflect the trial's current state.
Summary
The goal of this research is to use chromatin immunoprecipitation, a method used to study protein-DNA interaction, as a tool to diagnose and prognose pancreatic ductal adenocarcinoma in human samples. This is a Non-Human Subject Research study. All participants are de-identified.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2023-11-20; most recent amendment 2024-12-03.
Trial Details
NCT Number NCT06148298
Lead Sponsor University of Central Florida
Conditions Cancer of Pancreas
Enrollment 24 participants
Start Date 2023-05-24
Primary Completion 2025-05 (estimated)
Study Completion 2025-05 (estimated)
Updated on ClinicalTrials.gov 2024-12-06